{"url":"https://lda.gov/api/v1/filings/f5d6311c-a068-40fd-9f03-d203b4e9a658/","filing_uuid":"f5d6311c-a068-40fd-9f03-d203b4e9a658","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/f5d6311c-a068-40fd-9f03-d203b4e9a658/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Tim Casey","dt_posted":"2026-04-20T22:42:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12601 Twinbrook Parkway","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":400358632,"url":"https://lda.gov/api/v1/registrants/400358632/","house_registrant_id":null,"name":"THE UNITED STATES PHARMACOPEIAL CONVENTION","description":"Public health organization","address_1":"12601 Twinbrook Parkway","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY P. LAKAVAGE","contact_telephone":"+1 301-816-8334","dt_updated":"2026-07-30T11:25:36.781811-04:00"},"client":{"id":189520,"url":"https://lda.gov/api/v1/clients/189520/","client_id":12,"name":"THE UNITED STATES PHARMACOPEIAL CONVENTION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151460,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027: Provisions related to Administration for Strategic Preparedness and Response (ASPR) mapping. FY 2027 Commerce, Justice, Science, and Related Agencies Appropriations: Provisions related to 3D-printing. FY 2027 State-Foreign Operations Appropriations: Provisions related to pharmaceutical supply chain resilience.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151460,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}